Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Hyderabad
- Most recent report
- 6-K, filed Nov 5, 2026
- Incorporated
- N/A
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1135951
- Fiscal year ends
- March
- Filer status
- Large accelerated filer
Financials 8 of 956
- 6-K Report a foreign issuer made public elsewhere Nov 5, 2026
- 6-K Report a foreign issuer made public elsewhere Nov 4, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 29, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 29, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 26, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 26, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 23, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 23, 2026
Prospectuses and Registrations 1
Ownership 8 of 39
- 144 Notice of a proposed sale of restricted stock Nov 2, 2026
- 3 Insider reported their initial holding Apr 10, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
- 3 Insider reported their initial holding Apr 1, 2026
Other 4
Everything here comes from Dr Reddys Laboratories Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.